|
CDC Surveillance to Support Implementation of the National Action Plan for Chronic Obstructive Pulmonary Disease (COPD)
|
Health Survey
|
CDC
|
NHLBI
|
To provide surveillance support for the public health implementation of the new National Action Plan for chronic obstructive pulmonary disease (COPD). NHLBI will provide funds in FY2017 and FY2018 to CDC/NCCDPHP/DPH for implementation of the Respiratory Health Module in the CDC Behavioral Risk Factor Surveillance System (BRFSS) 2017.
|
|
CDC-NHLBI Urine Biomarker Collaboration
|
Committee, Work group, Advisory group, or Task Force
|
CDC
|
NHLBI, NCI, NIDDK, NINDS
|
The purpose of this work group is to conduct research on sodium and potassium biomarkers in the CDC''s NHANES and NHLBI cohort studies to improve monitoring of sodium intake in the US population. Research has included calibration studies on prediction of usual sodium intake and estimation of usual sodium intake in the US population.
|
|
CDC-NIH Lyme Disease Serum Sample Repository
|
Resource Development
|
CDC, OS
|
NIAID
|
Initiated in 2008, this resource was made available to the scientific community on a broad basis in late 2011. Lyme disease and related serum samples are available upon request for testing and comparison of new and current diagnostic tests with a common serum sample set for standardization. Samples are distributed by the CDC. CDC and NIH both provided support to acquire the samples and continue to work together to ensure the scientific community has access to samples needed for Lyme disease diagnostic test development.
|
|
CDC/ National Center for Health Statistics (NCHS) Balance/Dizziness Problems
|
Health Survey
|
CDC
|
NIDCD
|
The purpose of this agreement is for NIDCD to provide financial support to the National Center for Health Statistics (NCHS) for the inclusion of Balance/Dizziness Supplements for a representative sample of US adults (age 18+ years) and children (age 3–17 years) in the 2016 National Health Interview Survey (NHIS). Previously, NIDCD negotiated an IAA with NCHS for collaboration and funding of the 2008 Adult Balance/Dizziness Supplement and the 2012 Child Balance/Dizziness Supplement to the NHIS. The current fiscal year funds will provide partial support for the renewal of this collaborative effort between NCHS and NIDCD to fund the 2016 Adult and Child Balance/Dizziness Supplements to the NHIS. The new NHIS Supplements will include many of the same questions on Balance/Dizziness included in the earlier 2008 and 2012 studies, although revisions have been made to eliminate some questions in order to include new ones that higher on the current priority list. These questions on the new Balance/Dizziness Supplements will assist NIDCD to make program planning decisions on priorities with respect to the funding of research on the prevention of falls related to dizziness and balance. The results will also be analyzed for use in tracking the Department of Health and Human Services’ (DHHS) objectives in Healthy People 2020. Results from this nationally-representative survey of the US non-institutionalized, civilian population will help NIDCD make budget allocations to subject areas where needs are found to be most critical.
|
|
CDC/HRSA Advisory Committee (CHAC) for HIV/AIDS, Viral Hepatitis, STD and TB prevention
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA
|
NICHD, OD/DPCPSI/OAR
|
The CDC/HRSA Advisory Committee on HIV, Viral Hepatitis, and STD Prevention and Treatment shall advise the Secretary, HHS; the Director, CDC; and the Administrator, HRSA, regarding objectives, strategies, policies, and priorities for HIV, Viral Hepatitis, and STD prevention and treatment efforts including surveillance of HIV infection, AIDS, Viral Hepatitis, other STDs, and related behaviors; epidemiologic, behavioral, health services, and laboratory research on HIV/AIDS, Viral Hepatitis, and other STDs; identification of policy issues related to HIV/Viral Hepatitis/STD professional education, patient healthcare delivery, and prevention services; agency policies about prevention of HIV/AIDS, Viral Hepatitis and other STDs, treatment, healthcare delivery, and research and training; strategic issues influencing the ability of CDC and HRSA to fulfill their missions of providing prevention and treatment services; programmatic efforts to prevent and treat HIV, Viral Hepatitis, and other STDs; and support to the agencies in their development of responses to emerging health needs related to HIV, Viral Hepatitis, and other STDs.
|
|
CDC/National Institute of Occupational Safety and Health (NIOSH) for Audiometric Support for 3 NIDCD-Sponsored, Population-Based Surveys
|
Health Survey
|
CDC
|
NIDCD
|
The purpose of this agreement is to provide funding for scientific and technical support as well as quality assurance of three large audiometric examination surveys funded by NIDCD. These health surveys are: (1) The National Health and Nutrition Examination Survey (NHANES), (2) Age, Gene/Environment Susceptibility Study–Reykjavik Study (AGES–RS), and (3) the Early Childhood Longitudinal Study – Kindergarten Class of 2010/2011 (ECLS–K:2010/2011).
|
|
CDC’s Division of Select Agents and Toxins (DSAT) Work Group
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA
|
NIAID
|
The workgroup holds biweekly meetings to discuss the following: point of regulation of select toxins (Botulinum neurotoxins, Staphylococcal enterotoxins, Abrin, Ricin, Conotoxins, Saxitoxin, Tetrodotoxin, Diacetoxyscirpenol, T-2 toxin), natural environment, toxin exclusion limits, space decontamination, and potential updates to the CDC’s manual “Biosafety in Microbiological and Biomedical Laboratories.”
|
|
CDC’s Field Epidemiology Training Program (FELP) Cancer Curriculum
|
Training Initiative
|
CDC
|
NCI
|
CDC and NCI (Center for Global Health and Cancer Prevention Fellowship Program) are collaborating to add a cancer curriculum to CDC’s Field Epidemiology Training Program.
|
|
Center for AIDS Research (CFAR) Implementation Science Workshop
|
Meeting/ Workshop
|
CDC
|
OD/DPCPSI/OAR, NIMH
|
This is an activity that began in 2017, leading to the workshop in 2018. The workshop is focused on clarifying and furthering NIH''s and the Center for AIDS Research (CFAR) network''s roles in advancing HIV-related implementation science research. The workshop will include representatives from NIH, CDC, USAID, State representatives and other non-Federal partners.
|
|
Centers for Disease Control and Prevention (CDC)/Health Resources and Services Administration (HRSA) Advisory Committee on Human Immunodeficiency Virus (HIV), Viral Hepatitis and Sexually Transmitted Diseases (STD) Prevention and Treatment (CHACHSPT)
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, CDC, CMS, HRSA, IHS, OS, SAMHSA
|
OD/DPCPSI/OAR
|
The CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment advises the Secretary; the Director, CDC; the Administrator and Associate Administrator for HIV/AIDS, and HRSA regarding objectives, strategies, policies, and priorities for HIV and STD/hepatitis prevention and treatment efforts. These efforts include surveillance of HIV infection, AIDS, STDs/hepatitis, and related behaviors; epidemiologic, behavioral, health services, and laboratory research on HIV/AIDS and STDs/hepatitis; identification of policy issues related to HIV/STD/hepatitis professional education, patient healthcare delivery, and prevention services; agency policies about prevention of HIV/AIDS and other STDs, treatment, healthcare delivery, and research and training; strategic issues influencing the ability of CDC and HRSA to fulfill their missions of providing prevention and treatment services; programmatic efforts to prevent and treat HIV and STDs/hepatitis; and support to the agencies in their development of responses to emerging health needs related to HIV and other STDs/hepatitis.
|